TOPFUND WHERE YOUR MONEY GROWS
Home / Stocks / Sunil Healthcare Ltd.
SUNLOC

Sunil Healthcare Ltd. Share Price

Live price, chart and which mutual funds hold this stock

TopFund Score: 50/100 · Average See breakdown ↓
…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 25 Sep 2026

₹70.9

Change

-1.1 (-1.53%)

Open

₹72.0

Prev. Close

₹72.0

Day High

₹72.0

Day Low

₹70.39

Volume Analysis

Traded

139

Delivered

139

Delivery %

100.0%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (1)

  • •Low return on equity (6.01%)

Opportunities (0)

No signal for this stock

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹73.42 ₹72.71 ₹71.81 ₹71.1 ₹70.2 ₹69.49 ₹68.59
Fibonacci ₹72.71 ₹72.09 ₹71.72 ₹71.1 ₹70.48 ₹70.11 ₹69.49
Camarilla ₹71.34 ₹71.2 ₹71.05 ₹71.1 ₹70.75 ₹70.6 ₹70.46

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

—

1 Week

-2.88%

1 Month

-6.62%

3 Months

—

6 Months

—

1 Year

—

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹77.29

Current price is at or below the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

5.32%

Net margin 4.25% × asset turnover 0.53x × equity multiplier 2.36x

Company Overview

Sector

Healthcare

Market Cap

₹78 Cr

P/E (TTM)

21.1

ROE

6.01%

Book Value

₹67.9

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 23 Sep 2026. Not investment advice.

TopFund Analysis

Sunil Healthcare Ltd. lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 50/100. The strongest factor is Cash Flow (75/100), while Growth (0/100) is the weakest area to weigh before deciding. Notably: Low return on equity (6.01%).

TopFund Score — Fundamentals Quality

50/100 — Average

Data confidence: 75/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 27 Sep 2026 · How we calculate this →

Financial Strength

71

Growth

0

Valuation

63

Cash Flow

75

Corporate Governance

56

Momentum

73

Institutional Ownership

30

Business Quality

44

Liquidity

50

From Screener.in

  • +Stock is trading at 1.12 times its book value
  • −Company has low interest coverage ratio.
  • −The company has delivered a poor sales growth of -0.65% over past five years.
  • −Company has a low return on equity of 0.59% over last 3 years.
  • −Company has high debtors of 188 days.

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Intimation Of Book Closure For The Purpose Of 52Nd AGM And Cut Off Date For Remote-Evoting/E-Voting 14 Sep

52nd AGM on 28 Sept 2026; record date 21 Sept, book closure 22-28 Sept, e-voting 25-27 Sept.

Announcement under Regulation 30 (LODR)-Newspaper Publication 03 Sep

Copy of newspaper publications about dispatch of 52nd AGM Notice and Annual Report 2025-26 to shareholders of Company including book closure intimation etc.

Reg. 34 (1) Annual Report. 02 Sep

Sunil Healthcare submitted FY2025-26 annual report; 52nd AGM set for 28 September 2026 via VC/OAVM.

Notice Of 52Nd Annual General Meeting Of The Company/Remote E-Voting Facility/E-Voting Facility And Other Information 2 Sep 02 Sep
Announcement under Regulation 30 (LODR)-Newspaper Publication 21 Aug

Publication of notice in newspaper for updation of email id and enabling temporary facility for updation of email Id by shareholders with Evoting agency/ Video …

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Sales + 23 24 23 21 22 20 20 21 23 24 22 20 19
Expenses + 22 22 23 19 19 18 18 18 19 20 18 18 16
Operating Profit 1 1 -1 3 2 2 3 3 3 4 4 2 3
OPM % 3.64% 5.15% -2.78% 12.58% 10.28% 11.4% 13.2% 14.29% 14.44% 16.71% 16.58% 9.84% 15.43%
Other Income + 1 0 3 1 0 0 1 0 1 0 1 0 0
Interest 1 1 1 2 2 2 2 2 1 1 2 2 2
Depreciation 2 2 1 1 1 2 2 2 2 2 2 2 1
Profit before tax -1 -1 0 0 -1 -1 0 0 1 1 1 -1 0
Tax % -26.44% -25.34% -48.72% 5.88% 6.25% 7.69% 57.14% -28.57% 11.65% 23.66% 30.95% -258.95% -130.0%
Net Profit + -1 -1 0 0 -1 -1 -1 0 1 1 1 2 0
EPS in Rs -1 -1 0 0 -1 -1 -1 0 1 1 1 1 0
Raw PDF — — — — — — — — — — — — —

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 108 91 81 70 91 119 110 90 83 88 84
Expenses + 93 77 70 77 85 102 94 86 73 75 72
Operating Profit 15 14 11 -7 5 17 16 4 10 13 12
OPM % 13.97% 15.21% 13.92% -9.9% 5.9% 14.59% 14.63% 4.72% 12.42% 14.56% 14.77%
Other Income + 1 2 0 14 6 2 5 5 1 2 1
Interest 4 5 7 7 5 3 4 6 6 6 6
Depreciation 4 5 6 6 6 6 7 6 6 6 6
Profit before tax 8 6 -1 -6 -1 9 9 -3 -1 2 1
Tax % 36.25% 28.68% -20.45% -11.25% 16.36% 30.67% 29.5% -30.08% 16.53% -79.37% —
Net Profit + 5 4 -1 -5 -1 6 7 -2 -1 4 4
EPS in Rs 5 4 -1 -5 -1 6 7 -2 -1 4 3
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% —

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Reserves 33 37 37 34 33 40 46 58 57 59
Borrowings + 45 61 55 49 50 35 37 66 69 56
Other Liabilities + 31 34 36 36 27 25 28 24 26 39
Total Liabilities 119 142 138 130 121 110 121 158 162 165
Fixed Assets + 60 71 69 70 70 70 70 87 94 86
CWIP 0 0 2 0 0 2 0 6 0 2
Investments 0 0 0 0 1 1 0 0 0 0
Other Assets + 59 71 66 60 50 37 50 66 68 77
Total Assets 119 142 138 130 121 110 121 158 162 165
Equity Capital 10 10 10 10 10 10 10 10 10 10

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 11 5 15 4 17 23 7 -15 12 22
Cash from Investing Activity + -13 -17 -3 -3 -11 -4 -3 -10 -8 -3
Cash from Financing Activity + 2 11 -12 -2 -6 -19 -4 25 -4 -19
Net Cash Flow 0 -1 0 0 -1 0 0 -1 0 0
CFO/OP 82 50 134 -64 315 136 55 -344 111 173
Free Cash Flow -2 -10 9 4 10 13 4 -26 3 19

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 73.53% → 73.53%
  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Public 26.37% 26.37% 26.35% 26.37% 26.36% 26.37% 26.36% 26.38% 26.37% 26.36% 26.37% 26.37%
Promoters 73.53% 73.53% 73.53% 73.53% 73.53% 73.53% 73.53% 73.53% 73.53% 73.53% 73.53% 73.53%
DII 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Sunil Healthcare Ltd. (this stock) 78 21.1 1.12 6.01%
Mangalam Drug & Chem Ltd 50 — 0.49 -35.2%
Makers Laboratories Ltd. 107 31.4 1.48 3.17%
Vivimed Labs Limited 46 — -0.22 —
Vaishali Pharma Limited 112 25.2 1.63 6.02%
Vivo Bio Tech Ltd. 38 — 0.4 -2.0%
Gkb Ophthalmics Ltd. 36 9.69 0.66 3.28%

Which Mutual Funds Hold Sunil Healthcare Ltd.?

Frequently Asked Questions about Sunil Healthcare Ltd.

Community Sentiment

What are other investors saying about Sunil Healthcare Ltd.?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.